3,7,12-trihydroxycholestan-26-oic acid has been researched along with Liver Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bove, KE; Brewsaugh, T; Heubi, JE; Moser, A; O'Connell, NC; Setchell, KD; Squires, RH; Steinberg, SJ | 1 |
1 other study(ies) available for 3,7,12-trihydroxycholestan-26-oic acid and Liver Diseases
| Article | Year |
|---|---|
Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy.
Topics: Bile; Bile Acids and Salts; Biomarkers; Blood; Cholestanols; DNA Mutational Analysis; Female; Gas Chromatography-Mass Spectrometry; Humans; Infant, Newborn; Liver Diseases; Liver Transplantation; Metabolism, Inborn Errors; Mutation; Peroxisomes; Racemases and Epimerases; Spectrometry, Mass, Fast Atom Bombardment; Urine | 2003 |